Novo Nordisk seeks court order to halt Lilly GLP-1 ads as Merck announces HIV PrEP partnership
read at Endpoints ↗DealNeutral
Novo Nordisk asked a New Jersey federal court to temporarily block Eli Lilly's GLP-1 advertisements, claiming the ads are misleading.
Merck disclosed that it has entered into a partnership focused on HIV pre‑exposure prophylaxis (PrEP), though the terms of the deal were not detailed.
The briefing also mentioned additional moves by AbbVie, Genmab, Johnson & Johnson and Mannkind, but no further information was provided.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Novo asks court to block Lilly ads; Merck strikes HIV PrEP deal”
read at Endpoints ↗81 words · retrieved Jul 24
comments(0)
5-min edit window · permanent after that